The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells

ChemMedChem

Volumn 2, Issue 3, 2007, Pages 374-378

  Li, Jingyuan ^a   Wang, Xuemei ^a   Wang, Chunxia ^a   Chen, Baoan ^a   Dai, Yongyuan ^a   Zhang, Renyun ^a   Song, Min ^a   Lv, Gang ^a   Fu, Degang ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Biomarkers; Daunorubicin; Drug delivery; Drugresistant cancer cells; Gold nanoparticles

Indexed keywords

3 MERCAPTOPROPIONIC ACID; ANTINEOPLASTIC ANTIBIOTIC; BIOLOGICAL MARKER; DAUNORUBICIN; GOLD; METAL NANOPARTICLE;

ARTICLE; CELL STRAIN K 562; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RESISTANCE; FLUORESCENCE MICROSCOPY; HUMAN; METHODOLOGY; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

3-MERCAPTOPROPIONIC ACID; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL SURVIVAL; DAUNORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; GOLD; HUMANS; K562 CELLS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE;

EID: 34547441163     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200600264     Document Type: Article

References (25)

1. L. Nagle, R. Eritja, D. Fitzmaurice, D. Ryan, S. Cobbe, S. Connolly, J. Phys. Chem. B 2003, 107, 470-477.
2. A. B. Lowe, B. S. Sumerlin, M. S. Donovan, C. L. McCormick, J. Am. Chem. Soc. 2002, 124, 11 562-11 563.
3. S. Chen, K. Kimura, Langmuir 1999, 15, 1075-1082.
4. J. G. Worden, Q. Dai, A. W. Shaffer, Q. Huo, Chem. Mater. 2004, 16, 3746-3755.
5. J. M. de La Fuente, C. C. Berry, Bioconjugate Chem. 2005, 16, 1176-1180.
6. P. He, M. W. Urban, Biomacromolecules 2005, 6, 1224-1225.
7. T. Niazov, V. Pavlov, Y. Xiao, R. Gill, I. Willner, Nano Lett. 2004, 4, 1683-1687.
8. J. Matsui, K. Akamatsu, S. Nishiguchi, D. Miyoshi, H. Nawafune, K. Tamaki, N. Sugimoto, Anal. Chem. 2004, 76, 1310-1315.
9. G. P. Goodrich, M. R. Helfrich, J. J. Overberg, C. D. Keating, Langmuir 2004, 20, 10246-10251.
10. S. Shukla, A. Priscilla, M. Banerjee, R. R. Bhonde, J. Ghatak, P. V. Satyam, M. Sastry, Chem. Mater. 2005, 17, 5000-5005.
11. G. Acharya, C. L. Chang, C. Savran, J. Am. Chem. Soc. 2006, 128, 3862-3863.
12. K. Dill, L. H. Stanker, C. R. Young, J. Biochem. Biophys. Methods 1999, 21, 61-67.
13. Z. Ma, S. F. Sui, Angew. Chem. 2002, 114, 2280-2283;
14. Angew. Chem. Int. Ed. 2002, 41, 2176-2179.
15. G. M. Harbers, L. J. Gamble, E. F. Irwin, D. G. Castner, K. E. Healy, Langmuir 2005, 21, 8374-8384.
16. R. Krishna, L. D. Mayer, Eur. J. Cancer Sci. 2000, 11, 265-283.
17. K. Larsen, A. E. Escargueil, A. Skladanowski, Pharmacol. Ther. 2000, 88, 217-229.
18. I. Brigger, C. Dubernet, P. Couvreur, Adv. Drug Deliv. Rev. 2002, 54, 631-651.
19. M. Links, R. Brown, Expert Rev. Mol. Med. 1999, 1, 1-21.
20. M. K. Bhalgat, R. P. Haugland, J. S. Pollack, S. Swan, R. P. Haugand, J. Immunol. Methods 1998, 219, 57-68.
21. X. Gao, Y. Cui, R. M. Levenson, L. W. Chung, S. Nie, Nat. Biotechnol. 2004, 22, 969-976.
22. S. Santra, K. Wang, R. Tapec, W. Tan, J. Biomed. Opt. 2001, 6, 160-166.
23. O. C. Farokhzad, A. Khademhosseini, S. Jon, A. Hermmann, J. J. Cheng, C. Chin, A. Kiselyuk, B. Teply, G. Eng, R. Langer, Anal. Chem. 2005, 77, 5453-5459.
24. J. C. Sanford, F. D. Smith, J. A. Russell, Methods Enzymol. 1993, 217, 483-509.
25. C. J. Ackerson, P. D. Jadzinsky, R. D. Kornberg, J. Am. Chem. Soc. 2005, 127, 6550-6551.